ASE is excited to announce the ASE 2022 Scientific Sessions. ASE Scientific Sessions participants look to ASE to provide the latest information in diagnosis and management of all aspects of cardiovascular disease. In addition to the over 17,000 ASE members—clinicians, researchers, and other healthcare providers—who use both the established and latest innovations in cardiovascular ultrasound, an extensive prospect list will receive information about the upcoming conference.

Companies who partner with ASE will benefit from exposure to the largest cardiovascular imaging membership society with key cardiology decision makers who wield buying power or are influential in decision making. Device, technology, and medical equipment suppliers and pharmaceutical companies that provide products to cardiologists, private practices, and cardiovascular ultrasound laboratories cannot afford to miss this opportunity to showcase their products, services, and latest technological advances.